デフォルト表紙
市場調査レポート
商品コード
1378759

腸疾患検査市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
腸疾患検査市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の腸疾患検査市場規模は2022年に40億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに50億米ドルに達し、2022年から2028年にかけて3.8%の成長率(CAGR)を示すと予測しています。

腸疾患は、ウイルス、細菌、寄生虫などの微生物が口から体内に侵入することによって引き起こされます。これらの病原体は、汚染された食物や水、あるいは動物や感染者の排泄物に触れることで獲得することができます。腸疾患の一般的な症状は、腹部のけいれん、嘔吐、吐き気、食欲不振で、体内の水分や必要な栄養素が失われます。近年、診断技術の進歩により、腸疾患検査に革命が起こり、症状のある人の発見率が大幅に向上しました。

不適切な排水・衛生設備、安全でない飲料水、不衛生な生活環境は、腸疾患のリスクを著しく高める。このことは、近年の医療ツーリズムの大幅な増加とともに、市場成長を促す重要な要因の一つとなっています。これに加えて、早期診断の利点に関する個人の意識の高まりが、もう一つの主要な成長促進要因として作用しています。これとは別に、世界保健機関(WHO)や国連児童基金(UNICEF)のようないくつかの国際機関は、腸疾患の検査を促進するために、各国で啓発プログラムを実施し、ヘルスケアキャンプを設置しています。さらに、複数の主要企業が新規検査技術の商業化に注力しており、これが市場の成長に寄与しています。さらに、ヒトコロナウイルス症例は腸疾患と関連しているため、複数のヘルスケア機関が腸疾患とコロナウイルス疾患(COVID-19)の相互関係を見つけるための研究を実施しています。

本レポートで扱う主な質問

  • 世界の腸疾患検査市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • 主要な地域市場は?
  • COVID-19が世界の腸疾患検査市場に与えた影響は?
  • 製品タイプ別の市場内訳は?
  • 手法別の市場内訳は?
  • 疾患タイプ別の市場内訳は?
  • エンドユーザー別の市場内訳は?
  • 業界のバリューチェーンにおける様々な段階とは?
  • 業界の主要な促進要因と課題は何か?
  • 世界の腸疾患検査市場の構造と主要プレイヤーは?
  • 業界の競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 腸疾患検査の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品タイプ別

  • 試薬・消耗品
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測

第7章 市場内訳:技術別

  • 分子診断
    • 市場動向
    • 市場予測
  • 免疫診断
    • 市場動向
    • 市場予測

第8章 市場内訳:疾患タイプ別

  • 細菌性腸疾患
    • 市場動向
    • 主要タイプ
      • C.ジフィシル
      • カンピロバクター症
      • コレラ
      • 大腸菌
      • ピロリ菌
      • サルモネラ症
      • 赤痢
    • 市場予測
  • ウイルス性腸疾患
    • 市場動向
    • 主な種類
      • ロタウイルス
      • ノロウイルス
      • その他
    • 市場予測
  • 寄生性腸疾患
    • 市場動向
    • 主な種類
      • アメーバ症
      • クリプトスポリジウム症
      • ジアルジア症
    • 市場予測

第9章 市場内訳:エンドユーザー別

  • 病院診断ラボ
    • 市場動向
    • 市場予測
  • 独立系診断ラボ
    • 市場動向
    • 市場予測
  • 学術研究機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • BD(Becton, Dickinson and Company)
    • Bio-Rad Laboratories Inc.
    • Biomerica Inc.
    • Biomerieux SA
    • Cepheid Inc.(Danaher Corporation)
    • Coris BioConcept
    • DiaSorin
    • Meridian Bioscience Inc.
    • Quest Diagnostics
図表

List of Figures

  • Figure 1: Global: Enteric Disease Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Disease Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Enteric Disease Testing Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Enteric Disease Testing Market: Breakup by Technique (in %), 2022
  • Figure 5: Global: Enteric Disease Testing Market: Breakup by Disease Type (in %), 2022
  • Figure 6: Global: Enteric Disease Testing Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Enteric Disease Testing Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Enteric Disease Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Enteric Disease Testing (Reagents and Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Enteric Disease Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Enteric Disease Testing (Equipment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Enteric Disease Testing (Equipment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Enteric Disease Testing (Molecular Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Enteric Disease Testing (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Enteric Disease Testing (Immunodiagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Enteric Disease Testing (Immunodiagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Enteric Disease Testing (Viral Enteric Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Enteric Disease Testing (Viral Enteric Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Enteric Disease Testing (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Enteric Disease Testing (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Enteric Disease Testing (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Enteric Disease Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: North America: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: North America: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: United States: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: United States: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Canada: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Canada: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Asia Pacific: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Asia Pacific: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: China: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: China: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Japan: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Japan: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: India: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: India: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: South Korea: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: South Korea: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Australia: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Australia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Indonesia: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Indonesia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Europe: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Europe: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Germany: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Germany: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: France: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: France: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: United Kingdom: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: United Kingdom: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Italy: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Italy: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Spain: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Spain: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Russia: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Russia: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Latin America: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Latin America: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Brazil: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Brazil: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Mexico: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Mexico: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Middle East and Africa: Enteric Disease Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Middle East and Africa: Enteric Disease Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Enteric Disease Testing Industry: SWOT Analysis
  • Figure 80: Global: Enteric Disease Testing Industry: Value Chain Analysis
  • Figure 81: Global: Enteric Disease Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Disease Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Enteric Disease Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Enteric Disease Testing Market Forecast: Breakup by Technique (in Million US$), 2023-2028
  • Table 4: Global: Enteric Disease Testing Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
  • Table 5: Global: Enteric Disease Testing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Enteric Disease Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Enteric Disease Testing Market Structure
  • Table 8: Global: Enteric Disease Testing Market: Key Players
目次
Product Code: SR112023A2544

Abstract

The global enteric disease testing market size reached US$ 4.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2028, exhibiting a growth rate (CAGR) of 3.8% during 2022-2028.

Enteric diseases are caused by the entering of microorganisms, such as viruses, bacteria and parasites, in the body through the mouth. These pathogens can be acquired through contaminated food and water or by encountering feces of an animal or infected person. The common symptoms of enteric diseases are abdominal cramps, vomiting, nausea and anorexia that can lead to loss of fluids and essential nutrients from the body. In recent years, advancements in diagnostic technologies have revolutionized enteric disease testing and significantly increased the detection rates in symptomatic individuals.

The improper drainage and sanitation systems, unsafe drinking water and unhygienic living conditions can significantly increase the risk of enteric diseases. This, along with a substantial rise in medical tourism in recent years, represents one of the key factors impelling the market growth. Besides this, the increasing awareness among individuals about the benefits of early diagnosis is acting as another major growth-inducing factor. Apart from this, several international agencies, such as the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF), are conducting awareness programs and setting up healthcare camps in different countries to promote the testing of enteric diseases. Moreover, several key players are focusing on the commercialization of novel testing technologies, which is contributing to the market growth. Furthermore, as human coronaviruses cases are associated with enteric diseases, several healthcare institutes are conducting studies to find interrelation between enteric disease and the coronavirus disease (COVID-19).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global enteric disease testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, technique, disease type and end user.

Breakup by Product Type:

Reagents and Consumables

Equipment

Breakup by Technique:

Molecular Diagnostics

Immunodiagnostics

Breakup by Disease Type:

Bacterial Enteric Disease

C. Difficile

Campylobacteriosis

Cholera

E. Coli

H. Pylori

Salmonellosis

Shigellosis

Viral Enteric Disease

Rotavirus

Norovirus

Others

Parasitic Enteric Disease

Amebiasis

Cryptosporidiosis

Giardiasis

Breakup by End User:

Hospital Diagnostic Laboratories

Independent Diagnostic Laboratories

Academic and Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomerieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics.

Key Questions Answered in This Report:

  • How has the global enteric disease testing market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global enteric disease testing market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technique?
  • What is the breakup of the market based on the disease type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global enteric disease testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Disease Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technique

  • 7.1 Molecular Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunodiagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Disease Type

  • 8.1 Bacterial Enteric Disease
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 C. Difficile
      • 8.1.2.2 Campylobacteriosis
      • 8.1.2.3 Cholera
      • 8.1.2.4 E. Coli
      • 8.1.2.5 H. Pylori
      • 8.1.2.6 Salmonellosis
      • 8.1.2.7 Shigellosis
    • 8.1.3 Market Forecast
  • 8.2 Viral Enteric Disease
    • 8.2.1 Market Trends
    • 8.2.2 Major Types
      • 8.2.2.1 Rotavirus
      • 8.2.2.2 Norovirus
      • 8.2.2.3 Others
    • 8.2.3 Market Forecast
  • 8.3 Parasitic Enteric Disease
    • 8.3.1 Market Trends
    • 8.3.2 Major Types
      • 8.3.2.1 Amebiasis
      • 8.3.2.2 Cryptosporidiosis
      • 8.3.2.3 Giardiasis
    • 8.3.3 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital Diagnostic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Independent Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 BD (Becton, Dickinson and Company)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerica Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biomerieux SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Cepheid Inc. (Danaher Corporation)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Coris BioConcept
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 DiaSorin
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Meridian Bioscience Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Quest Diagnostics
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis